.png)
Insulin resistance is a condition in which the cells of your muscles, fat tissue, and liver stop responding properly to insulin — the hormone your pancreas produces to move glucose from your bloodstream into your cells for energy.
Think of insulin as a key and your cells as doors. In a healthy metabolic state, insulin unlocks the door for glucose to enter. With insulin resistance, those locks become sticky — the pancreas responds by producing more and more insulin to force the door open. For a while, this works. But the effort required keeps escalating — and the long-term consequences compound silently.
Insulin resistance can be present for 10 to 15 years before blood glucose rises enough to trigger a prediabetes or diabetes diagnosis. By the time glucose is elevated, significant metabolic and cardiovascular damage may already be underway.
The progression typically looks like this:
1. Compensated insulin resistance — Cells become less insulin-sensitive. The pancreas compensates. Blood glucose stays normal. Standard tests appear normal. This phase can last decades.
2. Hyperinsulinemia — Chronically elevated insulin promotes fat storage, inflammation, elevated triglycerides, and suppresses HDL. Abdominal weight gain accelerates.
3. Prediabetes — The pancreas can no longer keep up. Fasting glucose rises to 100–125 mg/dL or A1c reaches 5.7–6.4%.
4. Type 2 Diabetes — Fasting glucose exceeds 126 mg/dL or A1c reaches 6.5% or above. Beta cell function has declined significantly.
Common signs include:
• Abdominal weight gain — excess fat around the midsection, even with a normal overall BMI
• Fatigue after meals — especially after carbohydrate-heavy meals
• Difficulty losing weight despite caloric restriction
• Increased hunger and carbohydrate cravings, even shortly after eating
• Brain fog and difficulty concentrating
• Acanthosis nigricans — dark, velvety patches of skin at the neck, armpits, or groin
• Skin tags — particularly around the neck and armpits
• Irregular menstrual cycles — insulin resistance is closely linked to PCOS
Note: You don't need to be overweight to have insulin resistance. "TOFI" — Thin Outside, Fat Inside — describes people with a normal BMI who carry significant visceral fat around internal organs. Waist circumference (above 35 inches in women, 40 inches in men) is often a better indicator than BMI alone.
Lifestyle and acquired causes:
• Excess visceral fat — releases inflammatory signals that directly impair insulin signaling
• Physical inactivity — skeletal muscle is the largest glucose-consuming tissue; inactivity sharply reduces its glucose uptake
• High-glycemic diets — repeated large insulin releases from refined carbs desensitize receptors over time
• Poor sleep — even one week of less than 6 hours per night measurably worsens insulin sensitivity; cortisol directly antagonizes insulin's effects
• Chronic stress — elevated cortisol raises blood glucose and drives abdominal fat deposition
• Certain medications — corticosteroids, some antipsychotics, and certain HIV treatments
• Hypothyroidism
• Cushing's syndrome
• PCOS — insulin resistance is a central feature, and the two drive each other in a self-reinforcing cycle
• Family history of Type 2 diabetes or prediabetes
How It's Diagnosed — And Why Standard Tests Miss It
Most primary care visits include a fasting glucose or A1c test. These measure glucose — but insulin resistance can be present for over a decade with normal glucose levels because the pancreas is compensating. To detect it early, you need to measure insulin directly or use surrogate markers.
Key lab markers to know:
• Fasting Glucose — optimal below 90 mg/dL; standard screen but misses early IR
• Fasting Insulin — optimal below 7 µIU/mL; earliest marker of IR, often abnormal years before glucose rises. Must be ordered specifically — not included in standard panels.
• HOMA-IR — calculated as (Fasting Glucose × Fasting Insulin) ÷ 405. Below 1.5 is optimal; above 2.9 is significant IR.
• HbA1c — optimal below 5.4%; prediabetes threshold is 5.7%
• Triglycerides — optimal below 100 mg/dL; elevated TG is a direct consequence of hepatic insulin resistance
• HDL Cholesterol — optimal above 60 mg/dL; low HDL correlates strongly with insulin resistance
• TG:HDL Ratio — optimal below 1.5; above 3.0 is a strong surrogate for insulin resistance. Divide your TG by your HDL — it's already on your standard labs.
• hsCRP — optimal below 1.0 mg/L; chronic inflammation accelerates insulin resistance
Yes — and this is the most important message in this article. Insulin resistance is highly responsive to intervention. The NIH Diabetes Prevention Program trial showed lifestyle intervention reduced progression to Type 2 diabetes by 58% — more effective than metformin alone.
Evidence-based strategies:
• Weight loss of 5–10% of body weight produces measurable improvements in insulin sensitivity
• Resistance training builds skeletal muscle, the primary site of glucose disposal — more muscle means more insulin-independent glucose uptake
• Reducing refined carbohydrate intake lowers the glycemic stimulus driving insulin surges
• Improving sleep (7–9 hours) restores normal cortisol patterns and insulin sensitivity
• Stress management — chronic cortisol is a direct antagonist of insulin signaling
• Medications — metformin, GLP-1 receptor agonists (semaglutide, tirzepatide), and SGLT2 inhibitors all improve insulin sensitivity through different mechanisms
Meaningful improvements in HOMA-IR, fasting insulin, and TG:HDL can be seen in as little as 8–12 weeks with consistent changes. Full reversal of prediabetes is achievable within 6–18 months of structured metabolic care.
The Best Diet for Insulin Resistance
Prioritize: non-starchy vegetables, lean proteins, healthy fats (olive oil, avocado, nuts), low-glycemic fruits (berries, citrus), legumes, and whole grains in moderation.
Limit or avoid: refined carbohydrates, added sugars and sweetened beverages, ultra-processed foods, and excess alcohol.
Approaches with the strongest evidence include the Mediterranean diet, low-glycemic index diets, and low-carbohydrate diets.